l-Prolyl-l-leucyl-glycinamide and its peptidomimetic analog 3(R)-[(2(S)-pyrrolidylcarbonyl)amino]-2-oxo-1-pyrrolidineacetamide (PAOPA) attenuate haloperidol-induced c-fos expression in the striatum☆-Reference-Cited by-同舟云学术

l-Prolyl-l-leucyl-glycinamide and its peptidomimetic analog 3(R)-[(2(S)-pyrrolidylcarbonyl)amino]-2-oxo-1-pyrrolidineacetamide (PAOPA) attenuate haloperidol-induced c-fos expression in the striatum☆

Published:2000-02 Issue:2 Volume:21 Page:301-308
ISSN:0196-9781
Container-title:Peptides
language:en
Short-container-title:Peptides

Author:

Ott Michael C.,Costain Willard J.,Mishra Ram K.,Johnson Rodney L.

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Endocrinology,Physiology,Biochemistry

Reference69 articles.

1. Functional heterogeneity of the caudate-putamen as revealed by c-fos induction in response to D1 receptor activation;Arnauld;Mol Brain Res,1993

2. The effect of melanotropin-release inhibiting factor, its metabolites and analogs on 3H spiroperidol binding and 3H apomorphine binding sites;Bahargava;Gen Pharmacol,1983

3. Potentiation of levadopa effect by intravenous l-prolyl-l-leucyl-glycinamide in man;Barbeau;Lancet,1975

4. Newer therapeutic approaches in Parkinson disease;Barbeau,1978

5. Double blind evaluation of oral l-prolyl-l-leucyl-glycine amide in Parkinson disease;Barbeau;Can Med Assoc J,1976

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and allosteric modulation of the dopamine receptor by peptide analogs of l-prolyl-l-leucyl-glycinamide (PLG) modified in the l-proline or l-proline and l-leucine scaffolds;European Journal of Medicinal Chemistry;2013-11

2. PAOPA, a potent dopamine D2 receptor allosteric modulator, prevents and reverses behavioral and biochemical abnormalities in an amphetamine-sensitized preclinical animal model of schizophrenia;European Neuropsychopharmacology;2013-03

3. From MIF-1 to endomorphin: The Tyr-MIF-1 family of peptides;Peptides;2007-12

4. Antiparkinsonian activity of L-propyl-L-leucyl-glycinamide or melanocyte-inhibiting factor in MPTP-treated common marmosets;Movement Disorders;2007

5. Design and Synthesis of Photoaffinity-Labeling Ligands of the l-Prolyl-l-leucylglycinamide Binding Site Involved in the Allosteric Modulation of the Dopamine Receptor;Journal of Medicinal Chemistry;2005-11-30